Kolon TissueGene, Inc. (KOSDAQ:950160)

Market Cap	2.65T
Revenue	n/a
Net Income	n/a
Shares Out	81.52M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	618,145
Average Volume	414,388
Open	35,500
Previous Close	35,100
Day's Range	32,350 - 36,000
52-Week Range	12,040 - 59,300
Beta	-0.80
RSI	31.65
Earnings Date	n/a

About Kolon TissueGene

Kolon TissueGene, Inc. develops cell therapies to target various orthopedic diseases and degenerative disorders. The company is developing cell therapies for osteoarthritis and musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950160